Ginkgo Bioworks Holdings (DNA) EPS (Weighted Average and Diluted): 2019-2024
Historic EPS (Weighted Average and Diluted) for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to -$10.54.
- Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) fell 34.26% to -$1.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.19, marking a year-over-year increase of 52.05%. This contributed to the annual value of -$10.54 for FY2024, which is 42.62% up from last year.
- Latest data reveals that Ginkgo Bioworks Holdings reported EPS (Weighted Average and Diluted) of -$10.54 as of FY2024, which was up 42.62% from -$18.37 recorded in FY2023.
- In the past 5 years, Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) ranged from a high of -$0.10 in FY2020 and a low of -$50.20 during FY2022.
- For the 3-year period, Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) averaged around -$26.37, with its median value being -$18.37 (2023).
- As far as peak fluctuations go, Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) plummeted by 3,511.51% in 2022, and later spiked by 63.41% in 2023.
- Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) stood at -$0.10 in 2020, then crashed by 1,290.00% to -$1.39 in 2021, then slumped by 3,511.51% to -$50.20 in 2022, then spiked by 63.41% to -$18.37 in 2023, then surged by 42.62% to -$10.54 in 2024.